refuse this we give 2 mg phytomenadione (vitamin KI) orally at birth and at 12 and 24 hours of age.We await information on the efficacy of this oral regimen.Recent work by Cornelissen et al will further fuel the controversy as they suggest that a single dose of vitamin K, whether given orally or intramuscularly, is insufficient to protect against late haemorrhagic disease of the newborn.'I wonder whether, in the meantime, the adverse publicity surrounding vitamin K will result in a resurgence of this preventable condition; I hope that it remains a condition that is rarely seen.
No takes yet. Share an insight, caveat, or question.
Leporrier et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: